
Semax 10mg
Synthetic Neuropeptide for Neurotransmitter and Neuroplasticity Research
$35.00
Out of stock
SEMAX (For Research Use Only)
Synthetic Neuropeptide for Neurotransmitter and Neuroplasticity Research
Product Description
SEMAX is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) designed exclusively for laboratory research. Derived from a fragment of adrenocorticotropic hormone (ACTH) without hormonal activity, it is intended for use in controlled in vitro and preclinical animal studies to investigate neurotransmitter modulation, neuroplasticity, and cellular signaling pathways. Not for human consumption, therapeutic use, or diagnostic applications.Research Applications
In Vitro Studies: Suitable for cell culture experiments, such as investigating SEMAX’s effects on brain-derived neurotrophic factor (BDNF) expression or neurotransmitter signaling in neuronal cell lines (e.g., SH-SY5Y or PC12 cells) to study neuroplasticity mechanisms.
Preclinical Models: Ideal for animal-based research, such as rodent models (e.g., rats or mice) to examine SEMAX’s influence on neural repair or stress-related signaling pathways in controlled settings, such as models of induced hypoxia or neural injury.
Biochemical Analysis: Can be used to study peptide stability, receptor interactions, or downstream effects on cellular processes, such as dopamine, serotonin, or cyclic AMP production, in laboratory environments.
Mechanism of Action (Research Context)
SEMAX interacts with neuronal signaling pathways in experimental models, enabling researchers to study:
Modulation of BDNF expression or neurotransmitter systems (e.g., dopamine, serotonin) in neuronal cell cultures.
Effects on neuroplasticity or neural repair in preclinical animal models, such as mice subjected to controlled neurological stress protocols.
Interactions between peptide and cellular responses in controlled in vitro systems, such as primary neuronal cultures or brain slice preparations.
Product Specifications
Purity: ≥98% (verified by HPLC, with Certificate of Analysis provided).
Form: Lyophilized powder for reconstitution in laboratory-grade solvents.
Storage: Store at -20°C in a dry, controlled environment to maintain stability for research purposes.
Packaging: Supplied in sterile vials for laboratory use.
Important Notes
For Research Use Only: This product is strictly intended for laboratory research by qualified professionals. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes.
Researcher Verification: Orders require confirmation of institutional or academic affiliation to ensure compliance with RUO regulations.
Safety: Handle in accordance with laboratory safety protocols. Not tested for human safety or efficacy.
Ordering Information
Available for purchase by research institutions, academic laboratories, and biotechnology firms.
Each order includes a Certificate of Analysis from an FDA-registered manufacturer to ensure quality for research applications.
Disclaimer
SEMAX is provided exclusively for scientific research and is not approved for human consumption, medical use, or distribution outside of research settings. Any use beyond laboratory research is strictly prohibited. Customers are responsible for ensuring compliance with all applicable regulations.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.